학술논문
O-8 Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer
Document Type
Abstract
Author
Source
In Annals of Oncology July 2021 32 Supplement 3:S220-S221
Subject
Language
ISSN
0923-7534